GXP

Combination Products—Engineering the Future of Healthcare | IVT

Combination products are being developed in response to the increasing demands of patients requiring more advanced and more effective treatments There are less formal regulations governing combination products because the field is relatively new The US Food and Drug Administration’s Office of Combination Products was created in 2002 to oversee the regulatory lifecycle of combination products  Major market growth is projected for combination products over the next decade both in the US and abroad The drivers for combination products include patent life extension, more products and technologies...

This content is only available to IVT members.
Get help maintaining your knowledge in GMP - Medical Devices. Read More!

If you are already a member and you do not have access to this article, upgrade your membership.
Need help? Read our FAQs.




Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.